A worldwide movement is underway to oblige laboratories to provide an estimated glomerular filtration rate (eGFR) whenever serum creatinine concentration is measured at the request of a physician.

For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events.

STOCKHOLM, SWEDEN (UroToday.com) - Following radical cystectomy and urinary diversion, estimated glomerular filtration rate (eGFR) is routinely used to monitor renal function. Actual GFR, however, as ...

In patients with renal impairment, rocuronium and sugammadex are the primary choice for reversing neuromuscular blockade, ...

AstraZeneca AZN stock has risen 8.6% in the past month, mainly due to mixed fourth-quarter results and a positive update from ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ® (pegcetacoplan) ...

INNOVATE Corp. surged 150% after its subsidiary MediBeacon received FDA approval for its TGFR system. See why I rate VATE ...

Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli® (pegcetacoplan) for the treatment of C3 ...

IgA肾病（IgAN）是全球最常见的原发性肾小球疾病，临床表现多样，严重影响患者生活质量。近期举行的世界肾脏病大会（WCN ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.